多肽定制DOTA-[Tyr3]-Octreotide 编码 [177943-89-4]

上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。

名称 DOTA-[Tyr3]-Octreotide
编码 [177943-89-4]
别名 DOTA-[Tyr3]-Octreotide
纯度 80%,90%,95%,98%,99%
重量 1mg,5mg,10mg,50mg,100mg,1g
序列(单字母缩写) DOTA-fCYwKTCT-ol (C2&C7 bridge)
序列(三字母缩写) DOTA-DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt)(Cys2 and 7 bridge)
基本描述 This NYAD-2 peptide is NYAD-1 labeled with FITC (Ex/Em=493/517 nm). NYAD-1 is a cell-penetrating alphalpha-Helical peptide used as a potential HIV-1 inhibitor. The hydrocarbon-stapled structure enhances alpha helicity.
溶解度
分子量 1421.64
化学式 C65H90N14O19S2
存储条件 Store at -20°C. Keep tightly closed. Store in a cool dry place.
注释
Documents DOTA-[Tyr3]-Octreotide          编码     [177943-89-4]
Figures DOTA-[Tyr3]-Octreotide          编码     [177943-89-4]
Reference L.Kolby et al., Br. J. Cancer, 93, 1144 (2005) R.Valkema et al., J. Nucl. Med., 46, 83S (2005) M.de Jong et al., J. Nucl. Med., 46, 13S (2005) W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003) A.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003) Chinol, M. et al. Semin. Nucl. Med. 32,141(2002) De Jong, M. et al. semin Nucl. Med. 32,133(2002)
C端
N端
化学桥 (Cys2 and 7 bridge)